Jo Van Damme Selected Research

Interleukin-8A Receptors (Receptors, Interleukin 8A)

1/2012	The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer.
10/2011	The expression and role of CXC chemokines in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jo Van Damme Research Topics

Disease

46	Inflammation (Inflammations) 04/2022 - 01/2002
28	Neoplasms (Cancer) 10/2021 - 07/2002
19	Infections 01/2021 - 01/2002
13	Uveitis 04/2022 - 09/2004
12	Neoplasm Metastasis (Metastasis) 01/2012 - 07/2002
11	Rheumatoid Arthritis 01/2021 - 03/2002
10	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2003
8	Multiple Sclerosis 01/2018 - 01/2003
6	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 08/2006
5	Carcinoma (Carcinomatosis) 07/2010 - 07/2002
4	Arthritis (Polyarthritis) 01/2021 - 01/2006
4	Sarcoidosis (Schaumann Disease) 04/2020 - 01/2016
4	Necrosis 01/2020 - 01/2006
4	Epiretinal Membrane (Epiretinal Membranes) 01/2020 - 09/2006
4	Virus Diseases (Viral Diseases) 01/2016 - 11/2008
4	Melanoma (Melanoma, Malignant) 11/2014 - 06/2007
3	Pathologic Processes 01/2016 - 07/2005
3	Experimental Arthritis 01/2009 - 04/2007
2	Breast Neoplasms (Breast Cancer) 10/2021 - 11/2014
2	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 04/2018 - 01/2017
2	Atherosclerosis 01/2018 - 02/2011
2	Wounds and Injuries (Trauma) 01/2018 - 01/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017 - 07/2004
2	Neuroinflammatory Diseases 01/2014 - 10/2012
2	Colorectal Neoplasms (Colorectal Cancer) 10/2011 - 07/2010
2	Cerebral Malaria 05/2010 - 04/2008
2	Carcinogenesis 08/2009 - 08/2008
2	Sarcoma (Soft Tissue Sarcoma) 12/2007 - 01/2003
2	Retinal Detachment (Retinal Detachments) 09/2006 - 08/2006
2	Crystal Arthropathies 01/2006 - 05/2004
2	Infectious Arthritis (Septic Arthritis) 05/2004 - 11/2003
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 11/2003 - 01/2003
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 04/2022
1	Fibrosis (Cirrhosis) 01/2022
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

68	ChemokinesIBA 08/2021 - 07/2002
21	CytokinesIBA 01/2021 - 05/2004
15	LigandsIBA 08/2021 - 10/2003
14	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021 - 01/2002
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2002
11	CXC ChemokinesIBA 11/2014 - 01/2004
10	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 03/2002
9	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 03/2002
8	Peptides (Polypeptides)IBA 01/2022 - 01/2002
8	EnzymesIBA 01/2020 - 03/2002
8	Chemotactic FactorsIBA 04/2018 - 11/2003
7	Interleukin-8 (Interleukin 8)IBA 04/2018 - 01/2003
5	InterferonsIBA 08/2021 - 11/2003
5	Protein Isoforms (Isoforms)IBA 08/2021 - 07/2002
5	ImmunosorbentsIBA 01/2020 - 09/2004
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015 - 01/2006
4	GlycosaminoglycansIBA 01/2022 - 01/2014
4	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2009
4	InterleukinsIBA 08/2019 - 01/2009
4	CC ChemokinesIBA 02/2019 - 02/2003
4	Biological ProductsIBA 12/2017 - 12/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015 - 06/2007
4	Interleukin-17 (Interleukin 17)IBA 08/2012 - 12/2007
4	Interferon-gamma (Interferon, gamma)IBA 07/2010 - 11/2003
4	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2010 - 11/2003
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 02/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021 - 02/2011
3	Complement System Proteins (Complement)IBA 01/2021 - 10/2012
3	EpitopesIBA 01/2021 - 03/2002
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 12/2019 - 01/2016
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2019 - 01/2016
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2019 - 06/2015
3	Interleukin-10 (Interleukin 10)IBA 08/2019 - 05/2011
3	Protein-Arginine DeiminasesIBA 01/2013 - 09/2008
3	Chemokine ReceptorsIBA 06/2010 - 09/2006
3	Chemokine CXCL6IBA 12/2007 - 01/2004
3	Chemokine CCL4IBA 09/2006 - 10/2002
3	Chemokine CCL3IBA 09/2004 - 10/2002
2	Rituximab (Mabthera)FDA Link 04/2022 - 01/2021
2	Monoclonal AntibodiesIBA 04/2022 - 01/2021
2	GelatinasesIBA 01/2021 - 09/2004
2	AutoantibodiesIBA 01/2021 - 05/2020
2	AutoantigensIBA 05/2020 - 01/2003
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2020 - 06/2007
2	Retinaldehyde (Retinal)IBA 01/2020 - 02/2015
2	Interleukin-6 (Interleukin 6)IBA 12/2019 - 01/2016
2	Chemokine CXCL12IBA 01/2016 - 07/2010
2	oxyamylose (COAM)IBA 01/2014 - 11/2010
2	Immunologic Factors (Immunomodulators)IBA 07/2013 - 07/2013
2	CitrullineIBA 01/2013 - 09/2010
2	Arginine (L-Arginine)FDA Link 01/2013 - 01/2004
2	Interleukin-15 (Interleukin 15)IBA 08/2012 - 05/2011
2	Interleukin-8A Receptors (Receptors, Interleukin 8A)IBA 01/2012 - 10/2011
2	Amino Acids FDA Link 02/2011 - 01/2004
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2010 - 03/2007
2	Chemokine CCL18IBA 11/2003 - 07/2002
1	matrigelIBA 10/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Sepharose (Agarose)IBA 01/2021
1	GelatinIBA 01/2021

Therapy/Procedure

12	Therapeutics 04/2022 - 01/2004
2	Immunomodulation 01/2021 - 01/2018
2	Investigational Therapies (Experimental Therapy) 04/2018 - 10/2012
1	Cautery 10/2021